Evidence map›Paper›PMID 27798115›Full record

ArticleHuman molecular genetics2017

Lamina-associated polypeptide 1 is dispensable for embryonic myogenesis but required for postnatal skeletal muscle growth.

Ji-Yeon Shin, Iván Méndez-López, Mingi Hong, Yuexia Wang, Kurenai Tanji, Wei Wu, Leana Shugol, Robert S Krauss, William T Dauer, Howard J Worman

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Molecular Pathology of Laminopathies.Annual review of pathology · 2022
    Review
  7. Review
  8. LINCing Nuclear Mechanobiology With Skeletal Muscle Mass and Function.Frontiers in cell and developmental biology · 2021
    Review
  9. Review
  10. The intragenic microRNAThe Journal of biological chemistry · 2020
    Article
  11. Congenital myasthenic syndrome due to aBrain communications · 2020
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ji-Yeon ShinDepartment of Medicine.
Iván Méndez-LópezDepartment of Medicine.
Mingi HongDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Yuexia WangDepartment of Medicine.
Kurenai TanjiDepartment of Pathology and Cell Biology, College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Wei WuDepartment of Medicine.
Leana ShugolDepartment of Medicine.
Robert S KraussDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
William T DauerDepartment of Neurology.
Howard J WormanDepartment of Medicine.
Columbia University · USIcahn School of Medicine at Mount Sinai · USUniversity of Michigan–Ann Arbor · US

Funding

Pathogenesis of Emery-Dreifuss Muscular DystrophyR01AR048997 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WORMAN, HOWARD J · 2003 to 2024
$7.1M
NIAMS NIH HHS R01 AR048997
6 · The paper itself

Abstract

Lamina-associated polypeptide 1 (LAP1) is an integral protein of the inner nuclear membrane that has been implicated in striated muscle maintenance. Mutations in its gene have been linked to muscular dystrophy and cardiomyopathy. As germline deletion of the gene encoding LAP1 is perinatal lethal, we explored its potential role in myogenic differentiation and development by generating a conditional knockout mouse in which the protein is depleted from muscle progenitors at embryonic day 8.5 (Myf5-Lap1CKO mice). Although cultured myoblasts lacking LAP1 demonstrated defective terminal differentiation and altered expression of muscle regulatory factors, embryonic myogenesis and formation of skeletal muscle occurred in both mice with a Lap1 germline deletion and Myf5-Lap1CKO mice. However, skeletal muscle fibres were hypotrophic and their nuclei were morphologically abnormal with a wider perinuclear space than normal myonuclei. Myf5-Lap1CKO mouse skeletal muscle contained fewer satellite cells than normal and these cells had evidence of reduced myogenic potential. Abnormalities in signalling pathways required for postnatal hypertrophic growth were also observed in skeletal muscles of these mice. Our results demonstrate that early embryonic depletion of LAP1 does not impair myogenesis but that it is necessary for postnatal skeletal muscle growth.

Indexed as

AnimalsCarrier ProteinsCell DifferentiationCell ProliferationFemaleGene Expression Regulation, DevelopmentalMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMuscle DevelopmentMuscle, SkeletalMuscular DystrophiesMyoblastsMyogenic Regulatory FactorsCarrier ProteinsLAP1 protein, mouseMembrane ProteinsMyogenic Regulatory Factors

Identifiers

PMID27798115
PMCPMC6075563
OpenAlexW2546101033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.